Cancer News
Prolonged survival for older men with prostate cancer
Hormone therapy plus radiation reduced cancer deaths by nearly 50% in older men with prostate cancer compared to patients who received hormone therapy alone.
Eat properly and your breast cancer may never come back
Researchers found that providing nutrition education to breast cancer patients may help them prevent reoccurrence of the disease.
Certain lung cancer patients benefit from radiation and chemotherapy
In a clinical trial, stereotactic body radiation therapy (SBRT) combined with specific chemotherapy improved survival among certain stage 4 lung cancer patients.
New drug for advanced stomach cancer approved in Europe
A new drug has been approved to treat advanced stomach cancer or gastro-esophageal junction adenocarcinoma, following prior chemotherapy, in Europe.
Exercise and active lifestyle help prostate cancer survival
A new study shows that prostate cancer patients with active lifestyles have better survival rate: walking or biking for 20+ minutes a day can make a difference.
For bladder cancer patients, laparoscopic surgery has good outcomes
Outcomes after laparoscopic surgery for bladder cancer patients are comparable to open surgery: after 5 years, 66% of patients had no signs of recurrence.
Immunotherapy drug for melanoma gets approved by US FDA
Metastatic or unresectable melanoma is an aggressive disease. Patients whose tumor is not responding to current drug therapies have another treatment option.
New drug approved in EU as treatment for ovarian cancer
Olaparib gained European approval for the treatment of advanced BCRA-mutated ovarian cancer. It is the first "PARP inhibitor" for this type of cancer.
Ramucirumab approved for metastatic non-small-cell lung cancer
The US FDA approved ramucirumab (Cyramza) for the treatment of metastatic non-small-cell lung cancer in combination with docetaxel.
New promising drug in Hormone-Receptor positive breast cancer
A new study on experimental drug, Palbociclib, gives hope to women with advanced breast cancer as it doubled progression-free survival in patients.
Positive results for Herceptin in HER2-positive breast cancer patients
Herceptin, when combined with chemotherapy, improves significantly long-term survival of patients with HER-2 positive breast cancer.
Adding agents to standard treatment helps breast cancer patients
Adding Carboplatin or bevacizumab to standard chemotherapy treatment increased the proportion of breast cancer with no residual cancer detected at surgery.
Preventing recurrence in young breast cancer patients
Breast cancer patients who retained ovarian function after chemotherapy benefited by ovarian suppression, either with tamoxifen or with aromatase inhibitor.
Metastatic breast cancer patients benefit from combination treatment
Women with metastatic breast cancer benefited from a treatment combining eribulin and capecitabine in a clinical trial, as presented in the latest conference.
Lower dietary fat linked with improved breast cancer outcomes
Among patients with early stage breast cancer who reduced their dietary fat intake, death rates were much lower for those who had hormone-unrelated disease.
Multiple myeloma treatment with 3 drugs shows unprecedented benefit
Investigators have produced significantly improved results for treating multiple myeloma by adding a 3rd drug to the accepted 2-drug combination in a trial.
Early stage breast cancer patients under radiation therapy for too long
2/3 of early stage breast cancer patients receive longer radiation therapy than necessary after surgery (3-4 weeks longer than in the guidelines), in the USA.
New drug approved for acute lymphoblastic leukemia
Blinatumomab was approved by the U.S. Food and Drug Administration for the treatment of some forms of acute lymphoblastic leukemia.
Immunotherapy for Hodgkin lymphoma: breakthrough results
Scientists report that 87% of Hodgkin lymphoma patients who participated in an early-phase immunotherapy clinical trial experienced cancer remission.
Preventing clot recurrence in cancer patients: heparin vs warfarin
A study confirms that patients getting low-molecular-weight heparin are better protected against recurrence of clots (deep-vein thrombosis) compared to warfarin
Are popular alternative medicines a risk to cancer patients?
New research shows that the 10 most commonly asked complementary medicines interact with conventional cancer treatments, and this may be dangerous for patients.
Half a million cancer cases per year due to being overweight or obese
A new study shows that nearly 500,000 new cancer cases per year can be attributed to "high body mass index" (BMI, a metric of weight compared to height).
Advanced bladder cancer immunotherapy works in trial
Scientists have developed a breakthrough new treatment for advanced bladder cancer, a type which has not seen major treatment advances in the last 30 years.
Triple negative breast cancer patients should get genetic testing
A study found that most triple-negative breast cancer patients should undergo genetic screening to evaluate recurrence risk, and risk to other family members.
Gene mutations found to increase risk of second breast cancer
Women who have had a tumor in one breast, and who have genetic risk for breast cancer, are at higher than average risk to develop a tumor in the other.
FDA approves bevacizumab combined with chemotherapy for some ovarian cancers
The US FDA approved bevacizumab for treatment of patients with platinum resistant, recurrent epithelial ovarian, Fallopian tube, or primary peritoneal cancer.
Stomach cancer patients benefit from surgery plus chemoradiation
Patients who receive radiation therapy, in addition to chemotherapy after surgery for stomach cancer appear to have better survival rates.
Prostate cancer patients monitoring their disease have high quality of life
In an analysis, patients who decide to monitor their prostate cancer with their doctors have equal/better wellbeing, compared to those who treat it immediately.
Oral mucositis reduced for head and neck cancer patients in trial
Preliminary results from a phase 2 trial for a medication to help prevent oral mucositis have been positive for patients with head and neck cancer.
Targeted treatment may improve esophageal cancer patients' survival
A lung cancer drug was used in a trial against a type of esophageal cancer with EGFR gene duplication, and resulted in longer survival for those patients.